Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33(7):1624–33.

Article  PubMed  Google Scholar 

Xiu F, Stanojcic M, Diao L, Jeschke MG. Stress hyperglycemia, insulin treatment, and innate immune cells. Int J Endocrinol. 2014;2014: 486403. https://doi.org/10.1155/2014/486403.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shomali N, Mahmoudi J, Mahmoodpoor A, Zamiri RE, Akbari M, Xu H, et al. Harmful effects of high amounts of glucose on the immune system: an updated review. Biotechnol Appl Biochem. 2021;68(2):404–10. https://doi.org/10.1002/bab.1938.

Article  CAS  PubMed  Google Scholar 

Jafar N, Edriss H, Nugent K. The effect of short-term hyperglycemia on the innate immune system. Am J Med Sci. 2016;351(2):201–11. https://doi.org/10.1016/j.amjms.2015.11.011.

Article  PubMed  Google Scholar 

Mikhalchik EV, Lipatova VA, Basyreva LY, Panasenko OM, Gusev SA, Sergienko VI. Hyperglycemia and some aspects of leukocyte activation in vitro. Bull Exp Biol Med. 2021;170(6):748–51. https://doi.org/10.1007/s10517-021-05147-x.

Article  CAS  PubMed  Google Scholar 

Vanessa Fiorentino T, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des. 2013;19(32):5695–703.

Article  Google Scholar 

Park E-Y, Park J-B. High glucose-induced oxidative stress promotes autophagy through mitochondrial damage in rat notochordal cells. Int Orthop. 2013;37:2507–14.

Article  PubMed  PubMed Central  Google Scholar 

Codo AC, Davanzo GG, de Brito ML, de Souza GF, Muraro SP, Virgilio-da-Silva JV, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab. 2020;32(3):437-46.e5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Meng W. COVID-19 and diabetes: the contributions of hyperglycemia. J Mol Cell Biol. 2020;12(12):958–62. https://doi.org/10.1093/jmcb/mjaa054.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Preiser JC, Ichai C, Orban JC, Groeneveld ABJ. Metabolic response to the stress of critical illness. Br J Anaesth. 2014;113(6):945–54. https://doi.org/10.1093/bja/aeu187.

Article  CAS  PubMed  Google Scholar 

Téblick A, Gunst J, Langouche L, Van den Berghe G. Novel insights in endocrine and metabolic pathways in sepsis and gaps for future research. Clin Sci. 2022;136(11):861–78. https://doi.org/10.1042/cs20211003.

Article  CAS  Google Scholar 

Todd LA, Vigersky RA. Evaluating perioperative glycemic control of non-cardiac surgical patients with diabetes. Mil Med. 2021;186(9–10):e867–72.

PubMed  Google Scholar 

Weekers F, Giulietti AP, Michalaki M, Coopmans W, Van Herck E, Mathieu C, et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003;144(12):5329–38. https://doi.org/10.1210/en.2003-0697.

Article  CAS  PubMed  Google Scholar 

Manzanares W, Aramendi I. Stress hyperglycemia and its control with insulin in critically ill patients: current evidence. Med Intensiva. 2010;34(4):273–81. https://doi.org/10.1016/j.medin.2009.10.003.

Article  CAS  PubMed  Google Scholar 

Scheen M, Giraud R, Bendjelid K. Stress hyperglycemia, cardiac glucotoxicity, and critically ill patient outcomes current clinical and pathophysiological evidence. Physiol Rep. 2021;9(2): e14713. https://doi.org/10.14814/phy2.14713.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Derde S, Vanhorebeek I, Van den Berghe G. Insulin treatment in intensive care patients. Horm Res. 2009;71(1):2–11. https://doi.org/10.1159/000173736.

Article  CAS  PubMed  Google Scholar 

Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet. 2005;365(9453):53–9. https://doi.org/10.1016/s0140-6736(04)17665-4.

Article  CAS  PubMed  Google Scholar 

Elsayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Diabetes care in the hospital standards of care in diabetes—2023. Diabetes Care. 2023;46(Supplement_1):S267–78. https://doi.org/10.2337/dc23-s016.

Article  PubMed  Google Scholar 

Pavlou S, Lindsay J, Ingram R, Xu H, Chen M. Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity. BMC Immunol. 2018;19(1):24. https://doi.org/10.1186/s12865-018-0261-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun Q, Li J, Gao F. New insights into insulin: the anti-inflammatory effect and its clinical relevance. World J Diabetes. 2014;5(2):89–96. https://doi.org/10.4239/wjd.v5.i2.89.

Article  PubMed  PubMed Central  Google Scholar 

Chen H-S, Wu T-E, Jap T-S, Hsiao L-C, Lee S-H, Lin H-D. Beneficial effects of insulin on glycemic control and β-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy. Diabetes Care. 2008;31(10):1927–32. https://doi.org/10.2337/dc08-0075.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Green K, Brand MD, Murphy MP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes. 2004;53(Suppl_1):S110–8. https://doi.org/10.2337/diabetes.53.2007.S110.

Article  CAS  PubMed  Google Scholar 

van Niekerk G, Davis T, Patterton HG, Engelbrecht AM. How Does inflammation-induced hyperglycemia cause mitochondrial dysfunction in immune cells? BioEssays. 2019;41(5): e1800260. https://doi.org/10.1002/bies.201800260.

Article  CAS  PubMed  Google Scholar 

Derde S, Vanhorebeek I, Van Den Berghe G. Insulin treatment in intensive care patients. Horm Res Paediatr. 2009;71(1):2–11. https://doi.org/10.1159/000173736.

Article  CAS  Google Scholar 

Scherm MG, Wyatt RC, Serr I, Anz D, Richardson SJ, Daniel C. Beta cell and immune cell interactions in autoimmune type 1 diabetes: how they meet and talk to each other. Mol Metab. 2022;64: 101565. https://doi.org/10.1016/j.molmet.2022.101565.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009;155(2):173–81. https://doi.org/10.1111/j.1365-2249.2008.03860.x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Noble JA, Valdes AM, Varney MD, Carlson JA, Moonsamy P, Fear AL, et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes. 2010;59(11):2972–9. https://doi.org/10.2337/db10-0699.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krishnamurthy B, Mariana L, Gellert SA, Colman PG, Harrison LC, Lew AM, et al. Autoimmunity to both proinsulin and IGRP is required for diabetes in nonobese diabetic 8.3 TCR transgenic mice. J Immunol. 2008;180(7):4458–64. https://doi.org/10.4049/jimmunol.180.7.4458.

Article  CAS  PubMed